KRAS and neoplasm: Moreover, a study conducted by Chang et al. found that long-term repeated, nose-only inhalation exposure of K-ras lung cancer model mice to 4E-BP1 significantly reduced tumor size, thereby providing exciting new possibilities in NSCLC treatment [48].